| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.032 | 0.9 |